التفاصيل البيبلوغرافية
| العنوان: |
Efficacy of R‐GCVP in patients with late relapse of diffuse large B‐cell lymphoma. |
| المؤلفون: |
Djebbari, Faouzi, Browning, Joseph A., Stanton, Louise, Booth, Stephen, Hildyard, Catherine, Willan, John, Bosworth, Jenny, Vora, Sona M., Hatton, Chris S.R., Collins, Graham P., Eyre, Toby A. |
| المصدر: |
British Journal of Haematology; Sep2019, Vol. 186 Issue 6, pe191-e195, 5p, 1 Chart, 1 Graph |
| مصطلحات موضوعية: |
DIFFUSE large B-cell lymphomas, LYMPHOMAS, VENTRICULAR fibrillation |
| مستخلص: |
R-GCVP (rituximab, gemcitabine, cyclophosphamide, vincristine, prednisolone) is an effective upfront option for DLBCL patients considered unfit for anthracycline-containing immunochemotherapy due to cardiac comorbidity (Fields I et al i , [4]). We examined survival outcomes and toxicity of DLBCL patients receiving R-GCVP at relapse. R-GCVP was relatively well tolerated with clear efficacy in an elderly, consecutive patient cohort with late DLBCL relapse. To our knowledge, these are the first data to describe outcomes of R-GCVP in late DLBCL relapse patients. [Extracted from the article] |
|
Copyright of British Journal of Haematology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
